Flexible Stenting Solutions Inc. has announced the successful treatment of the first two patients enrolled in the OPEN (Evaluation of Safety and Efficacy of the FlexStent(R) FemorOPopliteal Self-Expanding StENt System) clinical trial.
EIZO has announced the introduction of the new RadiForce LX600W, a large widescreen LCD colour monitor with an LED backlight. This 8 megapixel monitor is designed for use in interventional radiology, cardiology, and surgery
Carotid stent use “Quality of Life” benefits were reduced to equivalence compared with surgery at the one year time point in a 2500 patient randomized multicentre study.
Sapheon Inc. has received CE Mark approval for its new approach to the treatment of varicose veins caused by venous reflux disease.
MAQUET Cardiovascular has announced that it has received both 510(k) clearance from the U.S. Food & Drug Administration (FDA) and CE mark approval for its new SENSATION PLUS™ 50cc 8 Fr. intra-aortic balloon catheter.
BIOTRONIK has announced the completion of enrollment in the BIOLUX P-I – a clinical study investigating the use of a drug-eluting balloon (DEB) catheter, a promising new approach to treating disease in the more challenging peripheral vascular anatomy.
Clearstream Technologies has agreed to be sold to Bard for 85p a share
The European Association of Cardiothoracic Surgeons (EACTS) Annual Meeting will take place in Lisbon, 1-5th October, 2011
The European Society for Vascular Surgery(ESVS) celebrates its 25th anniversary at its annual congress in Athens from Sept 22-25.
Angiographically determined aneurysm recurrence was less common with hydrogel-coated than with bare-platinum coils, but clinical relevance remains unclear.
Hemosphere Opens European Union Market for Future Growth Opportunities Building Upon
HeRO® Graft’s Success in the United States
Abbott has announced the initiation of ABSORB BTK, an international clinical trial evaluating the safety and efficacy of the ABSORB™ bioresorbable vascular scaffold (BVS) for the treatment of below-the-knee (BTK) critical limb ischemia.
Covidien has announced the start of patient enrollment in the ev3 DEFINITIVE(TM) Anti-Restenosis study taking place at Imelda Hospital in Belgium with Dr. Patrick Peeters.
Covidien has announced availability of the EverFlex+(TM) Self-Expanding Peripheral Stent System in Europe.